Past News
Abraham Verghese MD Appointed to the Board of Directors of Athos Therapeutics
"Abraham Verghese MD is a highly distinguished physician, humanist, administrator, and adviser," said Allan Pantuck, MD, MS, FACS, Chairman & CMO.
Johan Baeck MD Appointed EVP and CMO of Promontory Therapeutics
Johan Baeck MD joins Promontory Therapeutics from Jounce Therapeutics where he served as Senior Vice President, Clinical Development and Medical Affairs.
Sphere Fluidics Strengthens Commercial Team
The appointments form part of broader ongoing recruitment plans to support expanded operations and product development notes Sphere Fluidics.
Pierre Legault Appointed Egle Therapeutics Chairman and Board Member
Pierre Legault provides extensive experience over 35 years in leadership roles at leading companies across the biotech and pharmaceutical sector.
Global Virus Network Announces 7 Distinguished International Appointments to Board of Directors
The announcement was made today by Robert Gallo, MD, Co-founder of the Global Virus Network
Marufur Rahim Appointed the New Laboratory Technical Director at MicroCare
Marufur Rahim will be responsible for all laboratory staff, equipment, and supplies.
Dr Robert Arch Is Appointed President and CEO of OncoSec
Dr Robert Arch was previously Head of Research at Elpiscience Biopharma, Ltd. from October 2019 to June 2021, and Head of the Liver Disease Department at China Novartis Institutes for BioMedical Research from February 2017 to October 2019.
Exo Therapeutics Appoints Laura Kiessling to Scientific Advisory Board
“Dr. Kiessling’s creativity and broad scientific expertise will be crucial as we continue to build our platform and drive new programs to the clinic," said Michael Bruce, Ph.D., CEO of Exo Therapeutics.
Marco Baptista PhD Becomes New Chief Scientific Officer at the Christopher & Dana Reeve Foundation
Marco Baptista will help lead the Foundation's mission to advance cures for spinal cord injury (SCI) and paralysis
Michael Klichinsky PharmD PhD Becomes New Chief Scientific Officer of Carisma Therapeutics
Michael Klichinsky PharmD PhD, co-founder of Carisma Therapeutics, co-invented the company's proprietary and first-of-its-kind engineered macrophage platform.
Genya Dana PhD Joins Avellino as Global Head of Health Policy
Genya Dana PhD is a globally recognized scientific policy and genomics expert.
Omniose Announces Expanded Leadership Team to Develop Bioconjugate Vaccines Against Serious Bacterial Threats
Omniose notes Dr. Cooke has over 30 years of experience in the vaccine industry and is active in vaccine policy roles and more.
